FORMULARY DECISION
Baricitinib : Baricitinib
1265/17 : Treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic d...
Search Results
All Content Formulary Only Other ContentWe have found 12 results when searching "Baricitinib"
FORMULARY DECISION
Baricitinib : Baricitinib
SMC2337 : Treatment of moderate to severe atopic dermatitis in adult patients who are candidates for systemic therapy. SMC restriction: treatment of moderate to severe atopic dermatitis in adult patie...